Pharmacokinetics and biodistribution of polymeric micelles of paclitaxel with Pluronic P123

Acta Pharmacologica Sinica

Volumn 27, Issue 6, 2006, Pages 747-753

  Han, Li Mei ^a   Guo, Jie ^a   Zhang, Li Jun ^a   Wang, Qing Song ^a   Fang, Xiao Ling ^a  

^a FUDAN UNIVERSITY   (China)

Author keywords

Biodistribution; Micelle; Paclitaxel; Pharmacokinetics; Pluronic P123

Indexed keywords

PACLITAXEL; PLURONIC P123; POLOXAMER; POLYMER; SALICYLATE SODIUM;

ANIMAL TISSUE; AREA UNDER THE CURVE; ARTICLE; DRUG DISTRIBUTION; DRUG FORMULATION; DRUG HALF LIFE; DRUG RELEASE; DRUG SOLUBILITY; DRUG UPTAKE; FEMALE; IN VITRO STUDY; LIGHT SCATTERING; MICELLE; MORPHOLOGY; MOUSE; MOUSE STRAIN; NONHUMAN; PARTICLE SIZE; TECHNIQUE; TISSUE DISTRIBUTION; TRANSMISSION ELECTRON MICROSCOPY;

ANIMALS; ANTINEOPLASTIC AGENTS, PHYTOGENIC; AREA UNDER CURVE; DELAYED-ACTION PREPARATIONS; DRUG CARRIERS; DRUG DELIVERY SYSTEMS; FEMALE; MICE; MICELLES; PACLITAXEL; PARTICLE SIZE; POLOXALENE; RATS; RATS, SPRAGUE-DAWLEY; SOLUBILITY; TISSUE DISTRIBUTION;

EID: 33745423724     PISSN: 16714083     EISSN: 17457254     Source Type: Journal    
DOI: 10.1111/j.1745-7254.2006.00340.x     Document Type: Article

References (25)

1. Rowinsky EK Donehower RC. Paclitaxel (Taxol). N Engl J Med 1995 332 : 1004 14.
2. Spencer CM Faulds D. Paclitaxel. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic potential in the treatment of cancer. Drugs 1994 48 : 794 847.
3. Onetto N Canett R Winograd B Catane R Dougan M Grechko J, et al. Overview of taxol safety. J Natl Cancer Inst Monogr 1993 15 : 131 9.
4. Weiss RB Donehower RC Wiernik PH Ohnuma T Gralla RJ Trump DL, et al. Hypersensitivity reactions from taxol. J Clin Oncol 1990 8 : 1263 8.
5. Dorr RT. Pharmacology and toxicology of Cremophor EL diluent. Ann Pharmacother 1994 28 ( 5 Suppl S11 4.
6. Crosasso P Ceruti M Brusa P Arpicco S Dosio F Cattel L. Preparation, characterization and properties of sterically stabilized paclitaxel-containing liposomes. J Control Release 2000 63 : 19 30.
7. Lundberg BB Risovic V Ramaswamy M Wasan KM. A lipophilic paclitaxel derivative incorporated in a lipid emulsion for parenteral administration. J Control Release 2003 86 : 93 100.
8. Alkan-Onyuksel H Ramakrishnan S Chai HB Pezzuto JM. A mixed micellar formulation suitable for the parenteral administration of taxol. Pharm Res 1994 11 : 206 12.
9. Liu Y Chen GS Chen Y Cao DX Ge ZQ Yuan YJ. Inclusion complexes of paclitaxel and oligo(ethylenediamino) bridged bis (beta-cyclodextrin)s: solubilization and antitumor activity. Bioorg Med Chem 2004 12 : 5767 75.
10. Rodrigues P Scheuermann K Stockmar C Maier G Fiebig H Unger C, et al. Synthesis and in vitro efficacy of acid-sensitive poly(ethylene glycol) paclitaxel conjugates. Bioorg Med Chem Lett 2003 13 : 355 60.
11. Kataoka K Kwon GS Yokoyama M Okano T Sakurai Y. Block copolymer micelles as vehicles for drug delivery. J Control Release 1993 24 : 119 32.
12. Kataoka K Harada A Nagasaki Y. Block copolymer micelles for drug delivery: design, characterization and biological significance. Adv Drug Del Rev 2001 47 : 113 31.
13. Kabanov A Batrakova E Alakhov V. Pluronic block copolymers for overcoming drug resistance in cancer. Adv Drug Del Rev 2002 54 : 759 79.
14. Kabanov A Batrakova E Miller DW. Pluronic block copolymers as modulators of drug efflux transporter activity in the blood-brain barrier. Adv Drug Del Rev 2003 55 : 151 64.
15. Croy SR Kwon GS. The effects of Pluronic block copolymers on the aggregation state of nystatin. J Control Release 2004 95 : 161 71.
16. Kabanov A Batrakova E Alakhov V. Pluronic block copolymers as novel polymer therapeutics for drug and gene delivery. J Control Release 2002 82 : 189 212.
17. Kim SC Kim DW Shim YH Bang JS Oh HS Kim SW, et al. In vivo evaluation of polymeric micellar paclitaxel formulation: toxicity and efficacy. J Control Release 2001 72 : 191 202.
18. Zhang X Jackson J Burt H. Development of amphiphilic diblock copolymers as micellar carriers of taxol. Int J Pharm 1996 132 : 195 206.
19. Cho YW Lee J Lee SC Huh KM Park K. Hydrotropic agents for study of in vitro paclitaxel release from polymeric micelles. J Control Release 2004 97 : 249 57.
20. Huh KM Lee SC Cho YW Lee J Jeong JH Park K. Hydrotropic polymer micelle system for delivery of paclitaxel. J Control Release 2005 101 : 59 68.
21. Grindel JM Jaworski T Piraner O Emanuele RM Balasubramanian M. Distribution, metabolism, and excretion of a novel surface-active agent, purified poloxamer 188, in rats, dogs, and humans. J Pharm Sci 2002 91 : 1936 47.
22. Batrakova EV Li S Li Y Alakhov VY Elmquist WF Kabanov AV. Distribution kinetics of a micelle-forming block copolymer Pluronic P85. J Control Release 2004 100 : 389 97.
23. Gao Z Fain HD Rapoport N. Ultrasound-enhanced tumor targeting of polymeric micellar drug carriers. Molecular Pharmaceutics 2004 1 : 317 30.
24. Rowinsky EK Eisenhauer EA Chaudhry V Arbuck SG Donehower RC. Clinical toxicities encountered with paclitaxel (Taxol). Semin Oncol 1993 20 ( 4 suppl 3 1 15.
25. Rowinsky EK Donehower RC. The clinical pharmacology of paclitaxel (Taxol). Semin Oncol 1993 20 ( Suppl 2 16 25.